Jefferies Lowers PT on Solazyme to $22

October 18, 2011 7:15 AM | 8 seconds read | Make a Comment

Jefferies & Company has lowered the price target on Solazyme

SZYM

from $29 to $22 and maintains its Buy rating.

Posted In: Price Target Analyst Ratings Jefferies & Company

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.